Literature DB >> 8153033

Determinants of injecting insulin in elderly patients with type II diabetes mellitus.

B H Wolffenbuttel, C H Drossaert, A P Visser.   

Abstract

In patients with type II diabetes mellitus blood glucose control may gradually worsen despite diet and oral hypoglycaemic agents. We investigated which possible factors determine the decision for elderly type II diabetic patients to start with insulin therapy in this situation. According to Fishbein and Ajzen an attitude-behaviour model was constructed which included the determinants intention, attitude, subjective norm and self-efficacy. Fifty-three patients (age 68 +/- 9 years) participated in the study: 26 already used insulin for 7 months, 27 were tablet-treated but poorly-controlled (fasting blood glucose > 8.0 mmol/l and glycosylated haemoglobin > 8.0%). In both groups of patients, a high correlation (r = 0.81, P < 0.001) existed between the intention to and the actual start or continuation of insulin therapy. The main factor (70%) explaining the intention towards insulin treatment was the subjective norm: patients are guided by the opinion of important other persons, especially the treating internist, the family physician and the diabetes nurse. Tablet-treated patients reported a negative opinion of their physician towards their treatment with insulin. Intention to behaviour was also determined by self-efficacy, e.g. expectations about the skills concerning injecting insulin. Self-monitoring of blood glucose and knowledge about diabetes positively influenced self-efficacy, attitude towards and intention to use insulin. Education needs to enforce the subjective norm and improve the patient's self-efficacy. A stimulating attitude of the treating physician towards insulin therapy is essential.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8153033     DOI: 10.1016/0738-3991(93)90091-a

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  5 in total

1.  Delay in starting insulin after failure of other treatments in patients with type 2 diabetes mellitus.

Authors:  I Zografou; Mwj Strachan; J McKnight
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

Review 2.  Advances in the treatment of diabetes mellitus in the elderly. Development of insulin analogues.

Authors:  B J Hoogwerf; A Mehta; S Reddy
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

3.  Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors.

Authors:  Meryl Brod; Paul Valensi; Joseph A Shaban; Don M Bushnell; Torsten L Christensen
Journal:  Qual Life Res       Date:  2010-07-04       Impact factor: 4.147

Review 4.  Psychological insulin resistance: patient beliefs and implications for diabetes management.

Authors:  Meryl Brod; Jens Harald Kongsø; Suzanne Lessard; Torsten L Christensen
Journal:  Qual Life Res       Date:  2008-11-28       Impact factor: 4.147

5.  An exploration of barriers to insulin initiation for physicians in Japan: findings from the Diabetes Attitudes, Wishes And Needs (DAWN) JAPAN study.

Authors:  Hitoshi Ishii; Yasuhiko Iwamoto; Naoko Tajima
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.